Resources
Here, you will find a collection of case studies, fact sheets, articles, and media giving you insight into how we can support you throughout the clinical development journey and empower you with knowledge along the way.
World Lung Cancer Day Infographic
Lung cancer is the leading cause of cancer deaths worldwide, claiming more lives yearly than colon, breast, and liver cancers combined.
Media
Johnson & Johnson Guide to Expanded Access
Expanded Access offers a potential pathway to investigational treatment for patients who are ineligible to participate in clinical trials and have exhausted all available treatment options. The Johnson & Johnson Guide provides patients, their caregivers, and their physicians with much-needed clarity around their options at a moment when the power of information cannot be underestimated. Bionical Emas is proud to have collaborated on this first-of-its-kind Guide.
Media
Access to medicines: What you need to know
Naomi Litchfield, Director of Patient Advocacy at Bionical Emas, spoke to Laura Smith van Carroll, MMSc Head of Insight & Advocacy at Metabolic Support UK to share her thoughts and insights on what to expect as a metabolic patient and family when joining a clinical trial.
Media
Motor Neurone Disease (MND) Infographic
MND affects the cells in the brain and nerves, called motor neurones, this can lead to muscle weakness and loss of movement. Unfortunately, there is no cure for MND at this time, but there is a significant need to raise awareness about its symptoms and to support research to find effective treatments.
Media
Partnering for progress: Leveraging patient advocacy groups for better outcomes
Webinar hosted by Phormulate and sponsored by Bionical Emas
Media
The Patient Voice Podcast - Episode 1: Co-creating a clinical trial
This episode of The Patient Voice discusses the importance of collaboration when designing a clinical trial and how the early engagement of all stakeholders is critical to long-term success. Hear from those actively involved in this process on how they're achieving exactly that for a rare genetic condition.